Scythian Biosciences Corp (SCYB.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in thousands)
| 06-2025 | 03-2025 | 12-2024 | 09-2024 | 06-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 24 | 23 | 280 | 791 | 84 |
| Accounts receivable | 45 | -195 | 0 | 1,123 | 202 |
| Accounts payable and accrued liabilities | N/A | -215 | -92 | 3,274 | -2,275 |
| Other Working Capital | 130 | -673 | 618 | 4,659 | -3,620 |
| Other Operating Activity | -868 | -214 | -1,723 | -18,199 | 10,310 |
| Operating Cash Flow | $-669 | $-1,274 | $-917 | $-8,352 | $4,701 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | N/A | N/A | N/A | 13 |
| Net Acquisitions | 2,126 | -24 | 1,114 | 7,322 | N/A |
| Other Investing Activity | -923 | -584 | 212 | -3,401 | -3,910 |
| Investing Cash Flow | $1,202 | $-607 | $1,326 | $3,921 | $-3,897 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | 0 | -235 | N/A | N/A |
| Debt Issued | 128 | 480 | 675 | N/A | N/A |
| Debt Repayment | N/A | N/A | -190 | N/A | N/A |
| Common Stock Issued | 0 | 117 | 742 | -473 | 1,297 |
| Other Financing Activity | -808 | 1,059 | -1,124 | 5,166 | -2,402 |
| Financing Cash Flow | $-680 | $1,655 | $-132 | $4,693 | $-1,104 |
| Beginning Cash Position | 210 | 437 | 159 | 65 | 366 |
| End Cash Position | 64 | 210 | 437 | 159 | 65 |
| Net Cash Flow | $-146 | $-226 | $278 | $262 | $-301 |
| Free Cash Flow | |||||
| Operating Cash Flow | -669 | -1,274 | -917 | -8,352 | 4,701 |
| Free Cash Flow | -669 | -1,274 | -917 | -8,352 | 4,701 |